​
​

Eiger BioPharmaceuticals Ownership | Who Owns Eiger BioPharmaceuticals?

OverviewRevenueFinancialsChart

Eiger BioPharmaceuticals Ownership Summary

Eiger BioPharmaceuticals is owned by 41.86% institutional investors, and 58.14% retail investors. Simplify Propel Opportunities ETF is the top mutual fund, with 6.08% of its assets in Eiger BioPharmaceuticals shares.

EIGR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEiger BioPharmaceuticals41.86%-58.14%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202343-10.42%18,552,710-6.97%412.07%11-8.33%16-20.00%
Sep 30, 202348-25.00%19,942,909-4.07%452.03%12-52.00%20-28.57%
Jun 30, 202364-9.86%20,788,715-16.17%471.49%25-19.35%2816.67%
Mar 31, 202371-16.47%24,797,793-3.03%561.67%31-35.42%24-
Dec 31, 202285-13.27%25,572,536-16.00%581.21%48-5.88%24-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Simplify Propel Opportunities ETF90.00K6.08%-
Columbia Seligman Technology Growth77.31K5.22%8.00
BlackRock Extended Mkt Composite85.59K0.19%-
BlackRock Extended Equity Market K2.49K0.17%-
Northern Trust Extended Eq Market Idx1.25K0.08%-1.00
NT Ext Equity Mkt Idx Fd - L1.25K0.08%-1.00
NT Ext Equity Mkt Idx Fd - NL1.20K0.08%-1.00
Perinvest(Lux) Sicav Glb Hlthcare Eq B33.50K0.08%-
NT Ext Equity Mkt Idx Fd - DC - NL - T2964.000.07%-
BlackRock U.S. Equity Market F822.000.06%7.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 01, 2023KAYNE RICHARD A-Buy$27.97K
Oct 31, 2023KAYNE RICHARD A-Buy$31.50K
Oct 31, 2023KAYNE RICHARD A-Buy$3.23K
Oct 31, 2023KAYNE RICHARD A-Buy$3.15K
Nov 02, 2023KAYNE RICHARD A-Buy$6.97K

Insider Transactions Trends

DateBuySell
2023 Q47-
2023 Q3--
2023 Q2--
2023 Q112
2022 Q412

EIGR Ownership FAQ

Who Owns Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals shareholders are primarily institutional investors at 41.86%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Eiger BioPharmaceuticals's industry, Biotech Stocks , is 44.97%, which Eiger BioPharmaceuticals falls below.

Does Blackrock own Eiger BioPharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eiger BioPharmaceuticals.

Who is the top mutual fund holder of Eiger BioPharmaceuticals shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Eiger BioPharmaceuticals shares, with 6.08% of its total shares outstanding invested in 90K Eiger BioPharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools